However, in GBM, DKK3 only induces hyperactivation of the Wnt/β-catenin pathway by interacting with genes related to the Wnt/β-catenin pathway, which seems to have a significant effect on mortality and disease progression in patients with GBM. The gene discussed is DKK3; the disease is glioblastoma.